1. Home
  2. CNTA vs AVNT Comparison

CNTA vs AVNT Comparison

Compare CNTA & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.45

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Logo Avient Corporation

AVNT

Avient Corporation

HOLD

Current Price

$36.08

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTA
AVNT
Founded
2020
1927
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
3.4B
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
CNTA
AVNT
Price
$39.45
$36.08
Analyst Decision
Buy
Hold
Analyst Count
9
5
Target Price
$43.17
$41.50
AVG Volume (30 Days)
4.9M
466.5K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
2.98%
EPS Growth
29.13
N/A
EPS
N/A
0.89
Revenue
$15,000,000.00
$3,835,500,000.00
Revenue This Year
N/A
$4.90
Revenue Next Year
N/A
$3.48
P/E Ratio
N/A
$41.36
Revenue Growth
N/A
1.71
52 Week Low
$10.95
$27.48
52 Week High
$40.26
$44.85

Technical Indicators

Market Signals
Indicator
CNTA
AVNT
Relative Strength Index (RSI) 73.18 44.19
Support Level $39.16 $35.07
Resistance Level $40.26 $38.10
Average True Range (ATR) 0.20 1.02
MACD -0.47 -0.12
Stochastic Oscillator 47.54 6.57

Price Performance

Historical Comparison
CNTA
AVNT

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: